tradingkey.logo

Merit Medical Systems Inc

MMSI
87.390USD
-0.240-0.27%
收盤 12/24, 16:00美東報價延遲15分鐘
5.18B總市值
43.52本益比TTM

Merit Medical Systems Inc

87.390
-0.240-0.27%

關於 Merit Medical Systems Inc 公司

Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.

Merit Medical Systems Inc簡介

公司代碼MMSI
公司名稱Merit Medical Systems Inc
上市日期Oct 22, 2090
CEOAronson (Martha Goldberg)
員工數量7400
證券類型Ordinary Share
年結日Oct 22
公司地址1600 West Merit Park Way
城市SOUTH JORDAN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編84095
電話18012531600
網址https://www.merit.com/
公司代碼MMSI
上市日期Oct 22, 2090
CEOAronson (Martha Goldberg)

Merit Medical Systems Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
-5.23%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%
Mr. Neil W. Peterson
Mr. Neil W. Peterson
Chief Operating Officer
Chief Operating Officer
16.61K
--
Rear Adm. (Retd.) Stephen C. Evans
Rear Adm. (Retd.) Stephen C. Evans
Independent Director
Independent Director
6.81K
+46.21%
Mr. Michael R. (Mike) McDonnell, CPA
Mr. Michael R. (Mike) McDonnell, CPA
Independent Director
Independent Director
3.96K
-30.63%
Dr. F. Ann Millner, Ed.D.
Dr. F. Ann Millner, Ed.D.
Lead Independent Director
Lead Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
-5.23%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Peripheral Intervention
142.85M
37.35%
Cardiac Intervention
115.25M
30.13%
Custom Procedural Solutions
53.63M
14.02%
OEM
52.29M
13.67%
Endoscopy devices
18.44M
4.82%
地區USD
名稱
營收
佔比
United States
227.08M
59.37%
International
155.38M
40.63%
業務
地區
業務USD
名稱
營收
佔比
Peripheral Intervention
142.85M
37.35%
Cardiac Intervention
115.25M
30.13%
Custom Procedural Solutions
53.63M
14.02%
OEM
52.29M
13.67%
Endoscopy devices
18.44M
4.82%

股東統計

更新時間: 11月18日 週二
更新時間: 11月18日 週二
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.34%
The Vanguard Group, Inc.
11.18%
State Street Investment Management (US)
3.71%
Conestoga Capital Advisors, LLC
3.69%
Fuller & Thaler Asset Management Inc.
3.11%
其他
64.97%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.34%
The Vanguard Group, Inc.
11.18%
State Street Investment Management (US)
3.71%
Conestoga Capital Advisors, LLC
3.69%
Fuller & Thaler Asset Management Inc.
3.11%
其他
64.97%
股東類型
持股股東
佔比
Investment Advisor
54.11%
Investment Advisor/Hedge Fund
32.95%
Hedge Fund
10.11%
Research Firm
3.04%
Bank and Trust
2.31%
Individual Investor
2.26%
Pension Fund
1.63%
Sovereign Wealth Fund
1.02%
Family Office
0.40%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
736
64.29M
108.43%
-3.60M
2025Q2
756
65.62M
110.80%
-760.05K
2025Q1
779
66.66M
112.79%
+221.37K
2024Q4
755
63.98M
108.78%
+576.77K
2024Q3
725
62.16M
106.75%
-1.49M
2024Q2
695
63.02M
108.42%
-345.52K
2024Q1
677
61.08M
105.16%
-692.46K
2023Q4
651
59.77M
103.51%
-88.47K
2023Q3
637
57.87M
100.40%
-723.38K
2023Q2
625
56.54M
98.35%
-2.22M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
7.97M
13.46%
-206.62K
-2.53%
Jun 30, 2025
The Vanguard Group, Inc.
6.82M
11.51%
+257.10K
+3.92%
Jun 30, 2025
State Street Investment Management (US)
2.22M
3.75%
+24.57K
+1.12%
Jun 30, 2025
Conestoga Capital Advisors, LLC
2.21M
3.73%
-53.58K
-2.37%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.82M
3.07%
+52.67K
+2.98%
Jun 30, 2025
Maverick Capital, Ltd.
1.38M
2.33%
+106.90K
+8.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.44M
2.43%
+39.62K
+2.83%
Jun 30, 2025
Nomura Investment Management Business Trust
1.46M
2.46%
+4.15K
+0.29%
Jun 30, 2025
Fidelity Institutional Asset Management
1.09M
1.85%
-3.11K
-0.28%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月2日 週二
更新時間: 12月2日 週二
機構名稱
佔比
Invesco S&P SmallCap Health Care ETF
3.18%
First Trust Indxx Medical Devices ETF
2.22%
State Street SPDR S&P Health Care Equipment ETF
1.76%
Thrivent Small-Mid Cap ESG ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
0.71%
OneAscent Enhanced Small and Mid Cap ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.67%
iShares S&P Small-Cap 600 Growth ETF
0.66%
Franklin US Small Cap Multifactor Index ETF
0.66%
查看更多
Invesco S&P SmallCap Health Care ETF
佔比3.18%
First Trust Indxx Medical Devices ETF
佔比2.22%
State Street SPDR S&P Health Care Equipment ETF
佔比1.76%
Thrivent Small-Mid Cap ESG ETF
佔比0.91%
Invesco S&P SmallCap Low Volatility ETF
佔比0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
佔比0.71%
OneAscent Enhanced Small and Mid Cap ETF
佔比0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
佔比0.67%
iShares S&P Small-Cap 600 Growth ETF
佔比0.66%
Franklin US Small Cap Multifactor Index ETF
佔比0.66%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Merit Medical Systems Inc的前五大股東是誰?

Merit Medical Systems Inc的前五大股東如下:
BlackRock Institutional Trust Company, N.A.
持有股份:7.97M
佔總股份比例:13.46%。
The Vanguard Group, Inc.
持有股份:6.82M
佔總股份比例:11.51%。
State Street Investment Management (US)
持有股份:2.22M
佔總股份比例:3.75%。
Conestoga Capital Advisors, LLC
持有股份:2.21M
佔總股份比例:3.73%。
Fuller & Thaler Asset Management Inc.
持有股份:1.82M
佔總股份比例:3.07%。

Merit Medical Systems Inc的前三大股東類型是什麼?

Merit Medical Systems Inc 的前三大股東類型分別是:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)

有多少機構持有Merit Medical Systems Inc(MMSI)的股份?

截至2025Q3,共有736家機構持有Merit Medical Systems Inc的股份,合計持有的股份價值約為64.29M,占公司總股份的108.43% 。與2025Q2相比,機構持股有所增加,增幅為-2.37%。

哪個業務部門對Merit Medical Systems Inc的收入貢獻最大?

在FY2025Q2,Peripheral Intervention業務部門對Merit Medical Systems Inc的收入貢獻最大,創收142.85M,占總收入的37.35% 。
KeyAI